Nov 23 2026, 9:00am – 10:00am
Virtual
Join Pan-Canadian Research Connect for an engaging conversation with the Food and Drug Administration (FDA) to explore practical and operational strategies for integrating Quality by Design (QbD) principles into clinical trial planning and execution. The keynote presentation will be delivered by David Burrow, director, Office of Scientific Investigations and Office of Compliance, Center for Drug Evaluation and Research, FDA. The session will be moderated by Shila Rastegar, Health Canada Regulatory Operations and Enforcement (retired).